Pre-publication history
Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis
- † Equal contributors
BMC Medicine 2013, 11:1 doi:10.1186/1741-7015-11-1
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 17 May 2012 | |
| Reviewer's Report | Daniel Petrovic | 09 Jun 2012 | |
| Reviewer's Report | Alisa Manning | 20 Jul 2012 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 29 Aug 2012 |
| Reviewer's Report | Daniel Petrovic | 05 Sep 2012 | |
| Reviewer's Report | Alisa Manning | 10 Oct 2012 | |
| Resubmission - Version 3 | Manuscript | Author's comment | 29 Oct 2012 |
| Editorial acceptance | 16 Nov 2012 | ||
| Published | 02 Jan 2013 |
